Boundless Bio Inc (BOLD)
3.31
-0.27
(-7.54%)
USD |
NASDAQ |
Nov 14, 13:00
Boundless Bio Total Liabilities (Quarterly): 8.957M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 8.957M |
| March 31, 2024 | 258.26M |
| December 31, 2023 | 256.98M |
| Date | Value |
|---|---|
| September 30, 2023 | 259.78M |
| June 30, 2023 | 258.80M |
| December 31, 2022 | 158.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.957M
Minimum
Jun 2024
259.78M
Maximum
Sep 2023
200.22M
Average
257.62M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 188.20M |
| Shareholders Equity (Quarterly) | 179.25M |